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Introduction
============

Controlling fusion of intracellular organelles is essential to their functional integrity. This is particularly true for organelles of the secretory pathway that contain both resident enzymes and secretory proteins destined for the cell surface. Identities of secretory organelles, as defined by their enzymatic content, reflect the dynamic and highly regulated processes of selective delivery of lipid and protein by fusion with transport vesicles and selective removal of lipid and protein by budding of transport vesicles. Membrane fusion depends on the complementarity of transmembrane soluble *N*-ethylmaleimide (NEM)-sensitive factor attachment protein receptor (SNARE)[\*](#fn1){ref-type="fn"} proteins on opposing bilayers ([@bib53]; [@bib37]) and is influenced by the action of accessory factors such as Sec1p/unc-18 ([@bib29]; [@bib16]). Formation of a trans-SNARE complex is thought to catalyze actual bilayer fusion ([@bib22]). The complex is held together by a parallel four-helix bundle in which a vesicle SNARE (v-SNARE) contributes one helix and two or three target membrane SNAREs (t-SNAREs) contribute the other three ([@bib45]; [@bib55]; [@bib3]). After fusion, the resulting cis-SNARE complexes can be disassembled by the action of NEM-sensitive factor (NSF; Sec18p in yeast), a AAA ATPase ([@bib53]). Two general types of membrane fusion events can be distinguished ([@bib61]). Homotypic fusion occurs between like membranes having the same sets of v- and t-SNARE proteins and has been observed with endoplasmic reticulum ([@bib34]), Golgi ([@bib60]), early and late endosomes ([@bib38]; [@bib3]), and lysosomal/vacuolar membranes ([@bib61]). Heterotypic fusion occurs between target membranes having a t-SNARE complex and vesicle membranes bearing the cognate v-SNARE and has been studied extensively in the context of transport vesicle fusion with target organelles ([@bib48]) and secretory vesicle fusion with the plasma membrane ([@bib28]).

The trans-Golgi network (TGN) consists of a complex network of vesicles and tubules in continual communication with Golgi cisternae, early and late endosomes, and the cell surface. Numerous sorting, budding, and fusion events must occur in a coordinated fashion to maintain the functional integrity of the TGN and prevent undesirable mixing of endocytic and secretory cargo. The molecular details of how this is achieved are unclear. One approach toward understanding sorting in this organelle is to reconstitute TGN membrane fusion events.

We have developed an assay to monitor vesicular transport and membrane fusion events between the TGN and endosomal compartments in yeast. Using this assay, we have discovered a vigorous and previously uncharacterized membrane fusion event involving organelles containing the TGN resident enzymes Kex2p and Ste13p (dipeptidyl aminopeptidase \[DPAP\]A). Membrane fusion was energy and cytosol dependent. It was inhibited by rapid chelation of Ca^2^+ and the thiol-reactive reagent NEM.

Furthermore, the SNARE proteins Tlg1p, Tlg2p, and Vti1p, the rab5 homologue Vps21p, and the Sec1p homologue Vps45p, all of which have been implicated in late Golgi/endosomal function in vivo, are required for this reaction. NSF-sensitive SNARE complexes containing various combinations of Tlg1p, Tlg2p, and Vti1p have been isolated ([@bib30]; [@bib40]; [@bib18]). TGN homotypic fusion represents an event in which these three SNAREs appear to function together.

Results
=======

A new assay for fusion of membranes containing TGN resident enzymes
-------------------------------------------------------------------

The yeast integral membrane protease Kex2p, the prototype of the family of eukaryotic proprotein processing enzymes that includes furin, cleaves pro--α-factor and other precursors of secreted proteins in the late Golgi ([@bib24]; [@bib27]). After Kex2p cleavage of pro--α-factor, NH~2~ terminal dipeptides of α-factor intermediates are removed by the Ste13p DPAP ([@bib33]). Kex2p and Ste13p colocalize to the yeast equivalent of the TGN by virtue of signals in their cytosolic tails. These signals regulate their transport to and retrieval from post-Golgi compartments ([@bib46]; [@bib62]; [@bib63]; [@bib12]; [@bib41]; [@bib11]; [@bib13]). To better understand the trafficking and localization of TGN membrane proteins, we developed a sensitive quantitative assay for fusion of organelles containing Kex2p and Ste13p based on the mixing of their lumenal contents and their enzymatic activities ([Fig. 1](#fig1){ref-type="fig"} A). A Kex2p substrate was created by fusing an α-factor cleavage site followed by the triple hemagglutinin (HA) epitope tag to the lumenal COOH terminus of Ste13p (Ste13αHA). Expression of this modified form of Ste13p complemented a *ste13*Δ mutation for α-specific mating, indicating that it was functional in vivo (unpublished data). Fusion of membranes containing Ste13αHA with membranes containing Kex2p followed by Kex2p-mediated proteolytic cleavage after the Lys-Arg cleavage site within the α-factor repeat should separate the HA epitope tag from the DPAP domain ([Fig. 1](#fig1){ref-type="fig"} A). The cleaved product could then be quantified by measuring the fraction of DPAP activity that cannot be immunoprecipitated using anti-HA antibody (i.e., the fraction of the Ste13αHA that no longer has the HA tag). To determine if Ste13αHA was localized correctly and available for cleavage, we first examined whether Ste13αHA was processed by Kex2p in vivo. Ste13αHA was processed efficiently when coexpressed with Kex2p; whereas, the molecule was completely unprocessed when expressed in a *kex2*Δ strain ([Fig. 1](#fig1){ref-type="fig"} B). This indicated that the fusion protein was properly localized and that the α-factor cleavage site was accessible to Kex2p. We next examined Ste13αHA processing in a cell-free system. Cell-free extracts were prepared from semiintact yeast cells by freeze-thaw lysis and centrifugation ([@bib4]; [@bib49]) to produce a medium speed supernatant (MSS) fraction containing cytosol along with late Golgi and endosomal membranes but not ER or early Golgi ([Fig. 1](#fig1){ref-type="fig"} C, inset). Efficient Kex2p-dependent processing of Ste13αHA was observed when MSS membranes from a strain expressing Ste13αHA were incubated under reaction conditions with MSS membranes from a strain expressing Kex2p ([Fig. 1](#fig1){ref-type="fig"} C). Processing was blocked at 0°C ([Fig. 1](#fig1){ref-type="fig"} C) and was rapid, proceeding linearly for ∼10 min and reaching at 15 min a maximum level equivalent to cleavage of ∼35--40% of total Ste13αHA ([Fig. 1](#fig1){ref-type="fig"} D). Only a very short lag (\<1 min) was observed before processing began in contrast to cell-free vesicular transport reactions between Golgi cisternae ([@bib5]) from the ER to the Golgi ([@bib4]) or from the late endosome/prevacuolar compartment (PVC) to the lysosome ([@bib57]), all of which display a pronounced lag (∼10 min).

![**A new assay for fusion of membranes containing TGN resident enzymes.** (A) Schematic depiction of cell-free fusion assay. Vesicles isolated from JBY209 (*kex2*Δ *ste13*Δ) expressing Kex2p (represented by scissors-shaped protein) fuse with vesicles isolated from JBY209 expressing a Ste13αHA fusion protein containing a Kex2p cleavage site (α) between the lumenal DPAP domain and the HA tag. Cleavage of Ste13αHA by Kex2p separates the HA tag from the DPAP catalytic domain of Ste13. (B) in vivo processing of Ste13αHA by Kex2p. JBY209 expressing Ste13αHA was transformed with either pCWKX10 (*KEX2*) or a vector control (*kex2*Δ). Lysates were prepared, and the fraction of Ste13αHA processed was determined as described in Materials and methods. (C) Cell-free Kex2p processing of Ste13αHA. MSS membranes from either Kex2p-expressing cells or *kex2*Δ cells were combined with MSS membranes from JBY209 expressing Ste13αHA and incubated at either 0 or 30°C. (Inset) Western blot analysis of total lysates before centrifugation (Total) and supernatant fraction obtained by ∼14,000 *g* centrifugation (MSS) using polyclonal antibodies for organelle marker proteins: Wbp1p, wheat agglutinin binding protein (ER); Anp1p, subunit of cis Golgi mannosyl transferase complex (cis Golgi); Mnn1p, late acting mannosyl transferase (late Golgi); and Tlg1p, t-SNARE of the late Golgi (TGN). Plots in B and C show representative data from many experiments. (D) Time course of Ste13αHA processing. Fourfold scaled up reactions were incubated under reaction conditions. At the indicated times, duplicate 10-μl volumes were removed, and the amount of Ste13αHA processed was determined as described in Materials and methods.](0104093f1){#fig1}

To directly establish that membrane fusion had occurred and Kex2p and Ste13αHA were cointegrated into the same membranes at the end of the reaction, product membranes were immunoisolated using affinity purified antibodies directed against the Kex2p cytosolic tail ([@bib46]) by a method that results in quantitative isolation of membranes containing Kex2p ([@bib52]). If processing of Ste13αHA by Kex2p resulted from the fusion of compartments containing the two enzymes, then isolation of Kex2p-containing compartments should result in coisolation of DPAP activity. MSS membranes from the Kex2p- and Ste13αHA-expressing strains were incubated under reaction conditions either together ([Fig. 2](#fig2){ref-type="fig"} , Mixed) or separately ([Fig. 2](#fig2){ref-type="fig"}, Separate). "Separate" samples were combined at the end of the incubation. Incubation of the membranes together resulted in efficient processing of Ste13αHA (35%; [Fig. 2](#fig2){ref-type="fig"} A). The products of both reactions were then added to magnetic beads coated with affinity purified anti-Kex2p tail antibodies. After immunoisolation, beads were assayed for Kex2p and DPAP activity. In both samples, \>90% of Kex2p activity was associated with the beads after immunoisolation (unpublished data). In Kex2p-containing membranes immunoisolated from the "separate" reaction, no measurable DPAP activity was detected, whereas, ∼12% of the total DPAP activity from the "mixed" reaction was associated with the beads ([Fig. 2](#fig2){ref-type="fig"} B). This indicated that the observed Ste13αHA processing correlated with membrane fusion, resulting in membranes containing both Kex2p and DPAP activity.

![**Ste13**α**HA processing represents a membrane fusion event; DPAP activity is associated with immunopurified Kex2p vesicles.** (A) "Mixed" reaction was under standard reaction conditions. Control reaction (Separate) was set up as two half reactions containing MSS membranes from either Ste13αHA- or Kex2p-expressing strains, which were incubated separately at 30°C and then combined on ice. Half of each reaction was used to determine the fraction of Ste13αHA processed. (B) The remainder of the mixed and separate reactions was bound to anti-Kex2p beads, washed, and assayed for the percent of total DPAP activity, which remained bound to the beads. The somewhat lower yield of immunoisolated DPAP activity (12%) compared with the fraction processed (35%) likely resulted from fragmentation of the membranes during the isolation procedure.](0104093f2){#fig2}

Characteristics of the cell-free fusion reaction
------------------------------------------------

The cell-free membrane fusion that we observed exhibited features characteristic of other cell-free biological membrane fusion reactions. First, although Ste13αHA processing in the crude system did not require addition of exogenous ATP ([Fig. 3](#fig3){ref-type="fig"} A), omission of the ATP regeneration system completely blocked processing ([Fig. 3](#fig3){ref-type="fig"} A), indicating that the reaction was ATP dependent. Second, processing of Ste13αHA occurred with maximal efficiency between 25 and 30°C and was inhibited at temperatures below 15°C or above 35°C ([Fig. 3](#fig3){ref-type="fig"} B), similar to the temperature dependence of other cell-free biological membrane fusion reactions ([@bib4]; [@bib34]). Third, dilution of the MSS membranes progressively inhibited Ste13αHA processing, indicating that membrane concentration was important for efficient fusion ([Fig. 3](#fig3){ref-type="fig"} C). Fourth, addition of Triton X-100 (1% wt vol^−1^) completely inhibited Kex2p processing of Ste13αHA even though both Kex2p and DPAP were fully active under these conditions (unpublished data), indicating that membrane integrity was essential for efficient processing ([Fig. 3](#fig3){ref-type="fig"} D). Furthermore, this result shows that for processing to be observed in this dilute system Kex2p must be coconcentrated along with the substrate Ste13αHA in the lumenal space of fused late Golgi membrane vesicles. Taken together, the characteristics of the reaction suggested that the observed Kex2p-dependent processing of Ste13αHA represented a biologically relevant vesicular transport or membrane fusion event between membrane compartments containing Kex2p and Ste13αHA.

![**Characterization of in vitro TGN membrane fusion.** (A) Processing of Ste13αHA requires an ATP regeneration system. Control reactions (±Kex2p) included 1.5 mM exogenous Mg-ATP, 40 mM phosphocreatine, and 0.125 mg ml^−1^ creatine kinase. Omission of Mg-ATP (−ATP), or phosphocreatine/creatine kinase, (−Regen) is indicated. (B) Temperature dependence of Ste13αHA processing in vitro. Reactions were performed at each temperature using lysates from either *KEX2* or *kex2*Δ strains. (C) Dilution sensitivity of Ste13αHA processing. Reactions were diluted to the indicated extents before (Pre-reaction) or after (Post-reaction) incubation under reaction conditions. (D) Detergent sensitivity. MSS membranes from either *KEX2* or *kex2*Δ strains were combined with MSS membranes from a Ste13αHA-expressing strain, and reactions were performed in the presence or absence of 1% Triton X-100.](0104093f3){#fig3}

Membrane fusion events catalyzed by NSF/Sec18p are sensitive to NEM ([@bib9]). We observed partial inhibition of fusion by preincubation of lysates in the presence of NEM ([Fig. 4](#fig4){ref-type="fig"} A). Many membrane fusion events require Ca^2^+ ([@bib47]; [@bib6]; [@bib43]). Preincubation of MSS membranes with EGTA had no effect on fusion (unpublished data). In contrast, preincubation with the more rapid chelator BAPTA resulted in strong inhibition of fusion, which could be rescued by addition of millimolar concentrations of Ca^2^+ but not Mg^+2^ ([Fig. 4](#fig4){ref-type="fig"} B). This suggested that the Ca^2^+ required for membrane fusion might be released from a membrane-protected pool immediately before it functions as has been suggested in the case of other fusion events ([@bib21]; [@bib50]; [@bib43]). It was possible that this effect on the processing reaction was due to the Ca^2^+ dependence of Kex2p proteolytic activity ([@bib23]) rather than an effect on the fusion reaction itself, although the resistance to EGTA argued against this interpretation. Furthermore, coimmunoisolation experiments demonstrated that incorporation of Ste13αHA into Kex2p-containing membranes, not processing of Ste13αHA per se, was inhibited by BAPTA ([Fig. 4, C and D](#fig4){ref-type="fig"}). Examination of the kinetics of a reaction partially inhibited by BAPTA revealed that both the initial rate and extent of the reaction were reduced (unpublished data).

![**TGN membrane fusion is NEM-sensitive and requires Ca** ^2^+**.** (A) Donor and acceptor MSS membranes were treated separately with NEM or equimolar ratio of NEM + DTT at 30°C for 5 min. NEM was quenched with equimolar concentration of DTT on ice before initiating reactions. (B) MSS membranes were pretreated with 5 mM BAPTA, 7.5 mM CaCl~2~, or 7.5 mM MgCl~2~ for 1 h on ice. Higher processing of Ste13αHA was observed when 7.5 mM CaCl~2~ was added to standard reactions (unpublished data). To confirm that this additional processing was due to Kex2p, control reactions using *kex2*Δ MSS membranes were performed in the presence of 7.5 mM CaCl~2~. Complete inhibition could be achieved with higher BAPTA concentrations. However, at these BAPTA concentrations addition of equimolar Ca^2^+ did not restore more than 50% of the wild-type reaction (unpublished data). (C) BAPTA inhibits membrane fusion and not Kex2p activity. Mixed and separate reactions between MSS membranes pretreated with 5 mM BAPTA or buffer as in B were performed as described in the legend to [Fig. 2](#fig2){ref-type="fig"} A, and the fraction of Ste13αHA processed in each reaction is indicated (C). (D) The remainder of the mixed and separate reactions was bound to anti-Kex2p beads, washed, and assayed for the percent of total DPAP activity that remained bound to the beads as in the legend to [Fig. 2](#fig2){ref-type="fig"} B. Roughly 1% of the DPAP activity from the BAPTA-treated mixed reactions was associated with the anti-Kex2p beads, whereas 7% of the DPAP activity from the control mixed reaction (−BAPTA) coisolated with the beads, demonstrating that cointegration of the Ste13αHA and Kex2p into the same membranes and not simply the processing of the substrate by Kex2p was blocked by BAPTA.](0104093f4){#fig4}

Fusion was cytosol dependent. Membranes pelleted at 200,000 *g* (P200) to remove cytosol displayed poor processing, which could be stimulated in a concentration-dependent manner by addition of cytosol ([Fig. 5](#fig5){ref-type="fig"} A). The reconstituted processing reaction proceeded with slower kinetics and to a lesser extent, suggesting that the reaction depended on one or more labile components ([Fig. 5](#fig5){ref-type="fig"} B).

![**TGN membrane fusion is cytosol dependent.** (A) P200 membranes and cytosol were prepared and incubated as described in Materials and methods except that reactions were incubated for 40 min. The average of four experiments is shown, and error bars represent the standard deviation from the mean. (B) Fourfold scaled up reactions containing P200 membranes were incubated under reaction conditions in the presence (660 μg) or absence of cytosol. Time points were collected as in the legend to [Fig. 1](#fig1){ref-type="fig"}.](0104093f5){#fig5}

Tlg SNARE complex components are required for cell-free membrane fusion
-----------------------------------------------------------------------

To better define the nature of the reaction, we examined the role of t-SNARE proteins known to function late in the secretory pathway in the fusion reaction by observing the effects of treating the MSS membranes with specific antisera. Preincubation of membranes with antisera against the t-SNAREs Tlg1p, Tlg2p, Vti1p, and the Sec1p homologue, Vps45p, completely inhibited membrane fusion ([Fig. 6](#fig6){ref-type="fig"} A). In contrast, antiserum against Pep12p or the lumenal domain of Kex2p had no effect ([Fig. 6](#fig6){ref-type="fig"} A). Finally, consistent with the partial inhibition observed upon addition of NEM, preincubation with antiserum against Sec18p partially inhibited the reaction ([Fig. 6](#fig6){ref-type="fig"} A). To verify the specificity of inhibition by the various antisera, antigens in the form of purified tagged recombinant cytosolic domains (indicated as Δ--transmembrane domain \[TMD\]) of the SNARE proteins were used to compete with the inhibitory activity of the antisera. Addition of excess purified Tlg2ΔTMDp blocked inhibition by anti-Tlg2p serum ([Fig. 6](#fig6){ref-type="fig"} B), confirming the specificity of antibody inhibition. At levels of anti-Tlg1p antisera that inhibited ∼60% of fusion, preincubation of serum with 10 μg of purified Tlg1ΔTMDp blocked the majority of anti-Tlg1p inhibition ([Fig. 6](#fig6){ref-type="fig"} B). The antigen competition was specific for Tlg1p because an equivalent molar concentration of Vti1ΔTMDp (also 10 μg; the proteins have nearly identical molecular weights) was ineffective at blocking anti-Tlg1p inhibition ([Fig. 6](#fig6){ref-type="fig"} B). Antigen competition experiments with anti-Vti1p serum at levels that reduced membrane fusion by ∼60% required high levels of antigen (\>20 μM). These levels of Vti1ΔTMDp (antigen) inhibited fusion, presumably by a competition mechanism ([@bib8]; [@bib32]) even in the absence of antiserum ([Fig. 6](#fig6){ref-type="fig"} B). Significantly, addition of Vti1ΔTMDp to the anti-Vti1p--inhibited reaction restored membrane fusion to the same level observed in the presence of Vti1ΔTMDp antigen alone ([Fig. 6](#fig6){ref-type="fig"} B). As an additional control for the specificity of SNARE function in this reaction, we raised a new antiserum against the Tlg2p cytosolic domain (see Materials and methods) and compared the inhibitory effects of IgG purified from this new serum with IgG purified from antiserum raised against the ER/Golgi t-SNARE, Bet1p ([@bib54]) ([Fig. 6](#fig6){ref-type="fig"} C). After preincubation of MSS membranes with IgG levels roughly equivalent to 1 μl of unfractionated antiserum (∼6 μg), anti-Tlg2p IgG inhibited membrane fusion, whereas anti-Bet1 IgG had no effect. Taken together, these results argue for specific roles for Tlg1p, Tlg2p, and Vti1p and a potential role for Vps45p in the fusion reaction.

![**TGN SNARE complex is required for TGN membrane fusion.** (A) MSS membranes were combined on ice and incubated 1 h with 3--5μL of antisera (indicated above the appropriate bar). Reaction mix was then added and fusion was initiated at 30°C. Except for anti-Pep12p, all preincubations were performed in duplicate. Control represents the average of control reactions for each of the antiserum inhibition experiments. The data presented for anti-Pep12p and are representative of three separate experiments. (B) Inhibition by anti-Tlg2p, anti-Tlg1p, and anti-Vti1p is antigen specific. Anti-Tlg2p anti- serum was preincubated with 20 μg purified recombinant His~6~-Tlg2p lacking the COOH-terminal TMD (Tlg2) or with buffer for 1 h. Anti-Tlg1p antiserum was preincubated with 10 μg purified recombinant His-tagged Tlg1p lacking the COOH-terminal TMD (Tlg1) or with 10 μg purified recombinant His~6~-Vti1 lacking the COOH-terminal TMD (Vti1) as a control. Anti-Vti1p antiserum was preincubated with either 10 μg His~6~-Vti1ΔTMD (+Vti1), 25 μg His~6~-Vti1ΔTMD (++Vti1), or 10 μg His~6~-Tlg1ΔTMD (Tlg1). MSS membranes were then added to anti- serum and incubated on ice for 1 h before initiating fusion reactions at 30°C. (C) IgG purified from anti-Tlg2 antiserum inhibits membrane fusion, whereas IgG purified from anti-Bet1 antiserum does not. IgG was fractionated from serum proteins as described in Materials and methods and concentrated on microcon-10 spin columns to ∼1--2mg/ml. MSS membranes were combined on ice and incubated for 1 h with ∼6 μg anti-Tlg2p or anti-Bet1p IgG as indicated. After incubation under standard reaction conditions (described in Materials and methods), reactions were stopped by addition of Triton X-100 to 1% and precleared of IgG by 30 min incubation with pansorbin. Resulting IgG-depleted reactions were then subjected to anti-HA IP and mock IP as described in Materials and methods.](0104093f6){#fig6}

Vps21p rab protein is required on one of the two participating membranes for cell-free fusion to proceed
--------------------------------------------------------------------------------------------------------

All known membrane fusion events in the secretory pathway require a Ypt/rab protein ([@bib35]). To examine the role of the rab5 homologue Vps21p in this reaction, we prepared membranes from *vps21* mutant strains expressing either Kex2p or Ste13αHA. We observed an elevated fraction of DPAP activity in MSS membranes prepared from the *vps21* mutant strain that could not be precipitated by anti-HA (10%; as opposed to ≤2% observed in the case of wild-type strains), indicating that this fraction of the Ste13αHA had undergone Kex2-independent cleavage of the HA tag in vivo. Further Kex2-independent processing was not observed upon incubation of the membranes under reaction conditions ([Fig. 7](#fig7){ref-type="fig"} A). When Kex2p- and Ste13αHA-containing membranes prepared from *vps21* mutant strains were incubated together under reaction conditions, no additional processing of Ste13αHA above the elevated background level was observed ([Fig. 7](#fig7){ref-type="fig"} B, column 4 compared with 6). In contrast, normal levels of processing of Ste13αHA were displayed by reactions in which either the Kex2p- or the Ste13αHA-containing membranes were prepared from a wild-type *VPS21* strain ([Fig. 7](#fig7){ref-type="fig"} B). These results suggested that Vps21p was essential for the membrane fusion reaction and could be donated by either MSS fraction.

![**Vps21p function is required on only one membrane for TGN membrane fusion to proceed.** (A) MSS membranes from Ste13αHA-expressing *vps21* strain BLY9 were combined with either MSS from *kex2*Δ strain (JBY209) or buffer on ice. The samples were immunoprecipitated with anti-HA after incubations at either 30 or 0°C. (B) MSS membranes from Kex2p- or Ste13αHA-expressing *vps21* strain BLY9 (or JBY209 as *VPS21 kex2*Δ control) were combined as indicated under standard reaction conditions. Data are representative of three separate experiments performed using two different MSS preparations. (C) P200 membranes from JBY209 expressing Ste13αHA (*VPS21* Ste13αHA) were combined with MSS membranes from JBY209 (pCWKX10) (*VPS21 KEX2*), BLY9 (pCWKX10) (*vps21 KEX2*), or BLY9 (*vps21 kex2*Δ) under standard reaction conditions. Reactions in B and C were performed in duplicate.](0104093f7){#fig7}

Based on these data, it was possible that Vps21p function was required on only one of the two participating membranes. However, because Vps21p is found both on membranes and in the cytosol and presumably cycles between the two ([@bib31]), it was possible that the cytosolic pool of wild-type Vps21p supplied by the *VPS21* MSS could bind to the membranes from the *vps21* strain, providing functional Vps21p on both membranes. If this were the case, then mixing Ste13αHA-containing *VPS21* P200 membranes, from which the cytosolic pool of Vps21p had been removed, with Kex2p-containing *vps21* MSS (i.e., membranes plus cytosol) should not result in membrane fusion. However, as shown in [Fig. 7](#fig7){ref-type="fig"} C reactions containing P200 membranes from a Ste13αHA-expressing *VPS21* strain and MSS membranes from a Kex2p-expressing *vps21* strain supported a substantial level of fusion, two thirds as much as seen in a reaction containing P200 membranes from the Ste13αHA-containing *VPS21* strain and MSS from the Kex2p-containing *VPS21* strain. These data argue that the rab5 homologue Vps21p is required for the reaction and rab activity on either of the two participating membranes will suffice to support fusion.

Discussion
==========

We report here the reconstitution and characterization of a membrane fusion event involving organelles enriched in TGN resident enzymes. This reaction displayed characteristics of other biological membrane fusion reactions: it depended on ATP and cytosol, and it was inhibited by NEM and rapid Ca^2^+ chelation. Sensitivity of the reaction to BAPTA but not EGTA is consistent with a requirement for a transient utilization of Ca^2^+ during fusion as has been suggested for homotypic fusion of vacuoles ([@bib43]) and fusion of synaptic vesicles at the nerve terminus ([@bib21]; [@bib50]). The reaction was blocked by antisera against components of a late Golgi Tlg SNARE complex consisting of Tlg1p, Tlg2p, and Vti1p. Antisera against Vps45p also inhibited fusion, suggesting that Vps45p may function as the Sec1p component of this complex. Vps45p interacts both physically and functionally with Tlg2p and plays a role in multiple protein trafficking events originating at the TGN ([@bib20]; [@bib14]; [@bib40]; [@bib2]; [@bib7]). Vps21p rab function was required on one of the two membranes for fusion to proceed. Finally, we observed a partial requirement for Sec18p/NSF.

Mutations in the genes encoding the components of the Tlg SNARE complex give rise to distinguishable phenotypes, suggesting that each of these proteins catalyzes an unique set of fusion events ([@bib59]; [@bib2]; [@bib18]). The fusion event we measure here appears to represent one reaction in which these three proteins participate together. Consistent with our data, a t-SNARE complex of Tlg1p, Tlg2p, and Vti1p has been found to pair specifically with Snc1p to catalyze fusion when reconstituted in liposomes ([@bib42]). Preliminary evidence suggests that Snc1p is likely to function as the v-SNARE in conjunction with the Tlg SNARE complex in homotypic TGN fusion (unpublished data); however, this remains to be conclusively demonstrated. This study provides a biochemical assay for the coordinate function of all of these proteins in a single fusion event involving physiological membranes.

Steady-state localization of transmembrane proteins to the TGN in yeast depends on continuous cycles of transport between TGN and post-Golgi endosomal compartments ([@bib58]; [@bib17]; [@bib44]; [@bib19]; [@bib11]; [@bib13]). Thus, this reaction could hypothetically represent vesicular transport events between the TGN and the PVC. However, our data suggest that the reaction described here does not correspond to a vesicular transport event. First, the reaction did not display the extended lag phase typical of cell-free vesicular transport ([@bib5]; [@bib4]; [@bib57]). Second, whereas the PVC t-SNARE Pep12p is required for TGN to PVC transport and the class E Vps protein Vps27p is required for PVC to TGN transport, the reaction we observed required neither protein based on the following observations. Membranes prepared from a *pep12* temperature-sensitive mutant strain ([@bib15]) were able to support processing of Ste13αHA after a 5-min preincubation at the restrictive temperature to inactivate the protein (unpublished data). Moreover, anti-Pep12p antiserum failed to inhibit the reaction. Membranes prepared from *vps27*-null or temperature-sensitive mutants were fully competent to support processing of Ste13αHA (unpublished data). Finally, there was no requirement for the trans-Golgi localization signal (TLS)1 ([@bib11]) in the cytosolic tail of Kex2p, which would be required if the reaction involved transport of Kex2p from the PVC to the TGN (unpublished data).

Several lines of evidence argue that the reaction described here measures a homotypic fusion event. Homotypic fusion involves fusion of like organelles through the pairing of t-SNAREs and v-SNAREs distributed comparably onto the fusing membranes. In the case of homotypic vacuolar fusion, v-SNAREs can be genetically ablated from one membrane and t-SNAREs from the other and fusion can still proceed ([@bib61]). In contrast, heterotypic fusion requires pairing of a v-SNARE on a vesicle with t-SNAREs on the target membrane. The absence of either blocks the reaction. Ideally, mutations of SNARE genes therefore can allow the classification of a fusion reaction as homotypic or heterotypic as in the case of vacuolar fusion ([@bib61]). However, because the existence of the compartments to which our reporter proteins are localized depends on the components of the Tlg SNARE complex, such an experiment would be difficult to interpret. An alternative way to distinguish homotypic and heterotypic fusion is the sensitivity of the reaction to pretreatment of one of the membranes with antiserum against one of the participating SNARE proteins. We have found that in the reconstituted reaction involving pelleted membranes and cytosol pretreatment of either membrane before centrifugation with antisera against Tlg1p or Tlg2p was sufficient to completely inhibit the fusion reaction (unpublished data). Although this result is somewhat different from what was found in vacuolar fusion (see above), it argues that identical v- and t-SNAREs are present and are functional in the reaction on both of the fusing membranes, a necessary characteristic of homotypic fusion. Vps21p rab function was required, but on only one of the two membranes, to support membrane fusion. The symmetry inherent in the fact that rab activity on either membrane was sufficient supports the conclusion that the reaction occurs between two identical membranes.

Because both Kex2p and Ste13p cycle between the TGN and late endosomal compartments and possibly through early endosomal compartments (unpublished data) the fusion reaction between Kex2p- and Ste13αHA-containing membranes could represent homotypic fusion of TGN or early or late endosomal membranes. It seems unlikely that this reaction involves late endosomal/PVC membranes because (a) antibodies against Pep12p, the major late endosomal t-SNARE, did not inhibit the fusion reaction and (b) MSS membranes from *vps27*-null mutants, which accumulate aberrant late endosomal membranes, exhibited normal fusion activity (unpublished data). Subsets of components of the Tlg SNARE complex have been implicated in endocytosis (Tlg1p, Tlg2p, and Vps21p \[[@bib1]; [@bib51]; [@bib25]\]), biosynthetic traffic to the vacuole (Vti1p and Vps21p \[[@bib31]; [@bib59]\]), and early endosome homotypic fusion in mammalian cells (rab5/Vps21p; \[[@bib26]\]). These observations could implicate the involvement of early endosomal membranes in this reaction. Although this possibility cannot be excluded at this time, we believe it is more likely that the homotypic fusion reaction described here represents fusion of TGN membranes. First, up to 45% of Ste13αHA was processed in this cell-free reaction, suggesting that at least half of the Ste13αHA is localized to the membrane compartment that participates in the reaction. Ste13p has been shown to possess a strong TGN retention signal that slows its delivery to the late endosome, presumably by retarding its exit from the TGN ([@bib13]). Therefore, it is unlikely that the majority of Ste13αHA is localized to the endocytic compartments. Second, Tlg1p and Tlg2p have been colocalized with Kex2p in the late Golgi and have been shown to be required for its proper localization and activity ([@bib30]). These SNAREs do not colocalize extensively with Pep12p, a late endosomal marker, or with Sec7p, an early Golgi marker ([@bib36]).

We hope to use the cell-free fusion assay described here to analyze the function of the Tlg SNARE complex and identify the cytosolic components required for the reaction. The basic assay we have described may also be applied to reconstitute other transport and fusion events in the TGN/endosomal system by exploiting the use of distinct localization signals or accumulation in specific compartments to achieve differential localization of the enzyme (Kex2p) and substrate (Ste13αHA). Finally, these results call attention to the need for developing assays for TGN homotypic fusion in vivo in order to understand its importance for TGN membrane protein localization and TGN function.

Materials and methods
=====================

Antibodies and reagents
-----------------------

Monoclonal antihemagglutinin (HA) antibody 12CA5 was from Roche, and rabbit anti--mouse IgG and affinity purified goat anti--rabbit IgG/Fc fragment-specific were from Jackson ImmunoResearch Laboratories. Antisera against Pep12p/Vps45p, Vti1p, Tlg1p/Tlg2p, Bet1p, and Sec18p were provided by Drs. Scott Emr (University of California, San Diego, CA), Tom Stevens (University of Oregon, Eugene, OR), Hugh R.B. Pelham (Medical Research Council, Cambridge, UK), Randy Schekman (University of California, Berkeley, CA), and William T. Wickner (Dartmouth University, Hanover, NH), respectively. Polyclonal rabbit anti-Tlg2p antiserum used in [Fig. 6](#fig6){ref-type="fig"} C was raised against Tlg2p cytosolic domain purified from *Escherichia coli* as described for anti-Tlg2p antiserum obtained from Hugh R.B. Pelham (Medical Research Council) ([@bib30]). Polyclonal antisera were heat treated at 70°C for 45 min in a PerkinElmer 9600 thermocycler to inactivate serum DPAP.

FCS was from GIBCO BRL. Boc-Leu-Lys-Arg-7-amino-4-methylcoumarin (LKR-AMC) was from Bachem and Ala-Pro-AMC (AP-AMC) was from Enzyme Systems Products. Restriction endonucleases and DNA modification enzymes were from New England Biolabs, Inc. Unless indicated otherwise, all other chemicals and reagents were from Sigma-Aldrich.

Strains and plasmids
--------------------

The following strains were used: JBY209 (*ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 kex2*Δ*::hisG dap2*Δ*::kan* ^r^ *pep4*Δ*::HIS3 ste13*Δ*::LEU2 MAT*α), JBY209a (*isogenic with JBY209, except that it is MAT*a), and BLY9 (*his3 leu2 trp1 ura3 kex2*Δ*::hisG dap2*Δ*::kan* ^r^ *pep4*Δ*::HIS3 ste13*Δ*::LEU2 vps21*). BLY9 was constructed by crossing the vps21 allele from strain 0587-21 (provided by Dr. Scott Emr, University of California, San Diego, CA) into JBY209a and isolating His^+^, Leu^+^, G418^r^, Vps^−^, and kex2Δ segregants after sporulation. To create Kex2p- or Ste13αHA-expressing strains, plasmids pCWKX10 or pSTE13αHA, respectively, were introduced by transformation. Untransformed JBY209 was used as the kex2Δ control.

Plasmids pCWKX10 ([@bib63]), containing the *KEX2* gene under its own promoter, pTLG2HISN1 and pTLG1HISC1 ([@bib30]), and pET28aHis~6~VTI1ΔTMD ([@bib22]) have been described. Plasmid pSTE13αHA was constructed as follows. The *STE13* gene was amplified by PCR from pBRSTE13 (Jeremy Thorner, University of California, Berkeley, CA) using the following primers (5′ to 3′): GTTATTCGTGTAAAAAATCTAGAAAGCCCCTA, which anneals directly upstream of the start codon and introduces an XbaI site and CAATCATCCATAAAGAATTCTAAATGCAAA, which anneals at the end of *STE13* and both introduces an EcoRI site and changes the termination codon to GAA. The PCR product was ligated between the XbaI and EcoRI sites of p416TEF ([@bib39]). The resulting plasmid, pTEF-STE13, was digested with EcoRI and SalI and ligated to the following phosphorylated oligonucleotides, which had been annealed to each other (5′ to 3′): AATTGGATGCATCGGAATTCAGCGGCCGCTTG and TCGACAAGCGGCCGCTGAATTCCGATGCATCC. The resulting plasmid, pTEF-STE13 linker, was digested with NsiI and ligated to the following phosphorylated and annealed oligonucleotides (5′ to 3′): TGGCATTGGTTGCAACTAAAACCTGGCCAACCAATGTACAAGAGAGATGCA and TCTCTCTTGTACATTGGTTGGCCAGGTTTTAGTTGCAACCAATGCCATGCA, encoding the following amino acid sequence from prepro--α-factor: Trp His Leu Gln Leu Lys Pro Gly Gln Pro Met Tyr Lys Arg Asp Ala, confirmed by DNA sequencing. The resulting plasmid, pSTE13α, was digested with NotI and ligated to NotI-digested triple HA tag ([@bib56]), giving pSTE13αHA.

Preparation of membranes and cytosol
------------------------------------

Permeabilized cells were prepared from JBY209 containing pCWKX10 or pSTE13αHA as described ([@bib4]). Frozen spheroplasts (200 μl) were thawed (25°C, 2 min) and centrifuged (5 min, 14,000 rpm), and MSS fraction (containing microsomes and cytosol) was collected. For assays in which membranes were separated from cytosol, MSS membranes were diluted fourfold with lysis buffer and centrifuged through a 250-μl band of 12.5% ficoll in a TLS55 rotor (Beckman Coulter) at 55,000 rpm (200,000 *g* at r~avg~) for 1 h at 4°C to generate a high speed pellet fraction (P200). The P200 was resuspended in lysis buffer to 15% of the MSS volume and assayed for Kex2p or DPAP activity. P200 fractions were diluted to the same specific activity as the MSS membranes; 10 μl were used per reaction. Cytosol was prepared by centrifugation of MSS from JBY209 in a TLS55 rotor at 55,000 rpm for 1 h at 4°C and was concentrated on microcon-10 columns (Millipore) to a final protein concentration of 20--25 mg/ml as determined by the Bradford assay (Bio-Rad Laboratories).

Cell-free fusion
----------------

10 μl of MSS membranes from both the Kex2p- and Ste13αHA-expressing strains were added to 10 μl of 3× reaction mix (0.2 M sorbitol, 10 mM Hepes, pH 7, 75 mM KOAc, 4 mM MgOAc, 0.25 mM EGTA, 140 mM phosphocreatine, 0.375 mg ml^−1^ creatine kinase, and 9 mM CaCl~2~) on ice. Reactions were started by shifting to 30°C and unless indicated otherwise were incubated for 20 min. 10 μl were then removed and added to tubes containing either immunoprecipitation (IP) mix (1% Triton X-100, 1 mM EDTA, 20 μl pansorbin, 1 μl 12CA5 monoclonal anti-HA, and 1 μl rabbit anti--mouse IgG) or mock IP mix (1% Triton X-100, 1 mM EDTA, 20 μl pansorbin, and 2 μl water). IPs were incubated at RT with gentle agitation for 30 min. Pansorbin was pelleted, and 30 μl of each supernatant fraction were assayed for DPAP activity. The fraction of Ste13αHA processed was calculated as the ratio of DPAP activity in the supernatant fraction (i.e., the activity that was immunodepletion resistant) to the DPAP activity in the mock IP reaction (i.e., the total). Error bars represent the standard deviation of the average of at least two reactions.

Enzymatic assays
----------------

DPAP assays were performed as described ([@bib33]). The supernatant fraction from the IP reactions (30 μl) was added to 30 μl 2× DPAP reaction mix (240 mM Hepes, pH 8, 1% Triton X-100, 200 μM AP-AMC), and reactions were incubated in 96-well plates at 30°C in an *f* ~max~ plate fluorimeter (360 nm excitation/460 nm emission filter pair; Molecular Devices). Data were collected approximately every 20 s for 20 min. Kex2p was assayed as described ([@bib10]) except that LKR-AMC was used as substrate and 5 mM *o*-phenanthroline was included to inhibit a membrane-associated Kex2p-independent activity present in crude lysates ([@bib52]).

Immunoisolation of Kex2p membranes
----------------------------------

Anti-Kex2p cytosolic tail antibodies were affinity purified ([@bib46]). Dynabeads (Dynal) were covalently coated with affinity purified goat anti-rabbit IgG/Fc fragment-specific antibodies and bound to affinity purified anti-Kex2p tail antibodies as recommended by the manufacturer. Beads were washed three times with 50 mM Hepes, pH 7.0, 200 mM KOAc, 2 mM EDTA, and 5% FCS before use.

Reactions (scaled up twofold) were performed as described above. In control reactions, Kex2p- and Ste13αHA-expressing membranes were incubated separately in reaction mix and combined after incubation. At the end of the incubation, half of each reaction was processed for IP or mock IP to determine processing efficiency. The remainder (30 μl) was adjusted to 50 mM Hepes, pH 7.0, 200 mM KOAc, 2 mM EDTA, 5% FCS, and 0.8 M sorbitol in a final volume of 50 μl and added to 150 μg Dynabeads. Binding was performed for 2 h with slow rotation at RT. Beads were isolated magnetically, washed three times with cold 50 mM Hepes, pH 7, 200 mM KOAc, and 0.8 M sorbitol and assayed for Kex2p and DPAP activity.

Preparation of soluble domains of Tlg2p, Tlg1 p, and Vti1p
----------------------------------------------------------

His~6~-Tlg2ΔTMDp was expressed in *E. coli* BL21 (DE3) and purified using ProBond™ (Invitrogen) according to manufacturer\'s denaturing protocol. Recombinant protein was eluted with 20 mM NaPO~4~, pH 4.0, and 1 M urea. Fractions enriched for recombinant protein were pooled, dialyzed in 20 mM NaPO~4~, pH 7.0, 1 M urea, and concentrated to 10--20 mg ml^−1^ on microcon-10 columns. Tlg1-His~6~ΔTMDp and His~6~-Vti1ΔTMDp were expressed and purified as described above except that denaturants were omitted during lysis and purification and elution was performed with 400 mM imidazole-HCl in 20 mM NaPO~4~, pH 7.4, and 500 mM NaCl.

Antigen competition
-------------------

Polyclonal antiserum (∼100 μg total protein) was incubated with 10--40 μg recombinant protein on ice for 1 h. Antigen-saturated serum was then incubated with MSS membranes on ice for 1 h, and the membranes were tested for fusion competence.

IgG purification
----------------

Antisera were dialyzed overnight in 500-vol 20 mM KPO~4~, pH 7.2. Dialyzed serum was loaded onto a column containing equal volumes of CM- and DEAE-Sepharose. Flow through was collected and concentrated on microcon-10 columns. IgG purity and concentration were determined by SDS-PAGE and the Bradford assay.
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